» Articles » PMID: 9971834

Productive Infection of Human Peripheral Blood Mononuclear Cells by Feline Immunodeficiency Virus: Implications for Vector Development

Overview
Journal J Virol
Date 1999 Feb 11
PMID 9971834
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Feline immunodeficiency virus (FIV) is a lentivirus causing immune suppression and neurological disease in cats. Like primate lentiviruses, FIV utilizes the chemokine receptor CXCR4 for infection. In addition, FIV gene expression has been demonstrated in immortalized human cell lines. To investigate the extent and mechanism by which FIV infected primary and immortalized human cell lines, we compared the infectivity of two FIV strains, V1CSF and Petaluma, after cell-free infection. FIV genome was detected in infected human peripheral blood mononuclear cells (PBMC) and macrophages at 21 and 14 days postinfection, respectively. Flow cytometry analysis of FIV-infected human PBMC indicated that antibodies to FIV p24 recognized 12% of the cells. Antibodies binding the CCR3 chemokine receptor maximally inhibited infection of human PBMC by both FIV strains compared to antibodies to CXCR4 or CCR5. Reverse transcriptase levels increased in FIV-infected human PBMC, with detection of viral titers of 10(1.3) to 10(2.1) 50% tissue culture infective doses/10(6) cells depending on the FIV strain examined. Cell death in human PBMC infected with either FIV strain was significantly elevated relative to uninfected control cultures. These findings indicate that FIV can productively infect primary human cell lines and that viral strain specificity should be considered in the development of an FIV vector for gene therapy.

Citing Articles

Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Power C J Neurovirol. 2017; 24(2):220-228.

PMID: 29247305 DOI: 10.1007/s13365-017-0593-1.


Feline Immunodeficiency Virus Neuropathogenesis: A Model for HIV-Induced CNS Inflammation and Neurodegeneration.

Meeker R, Hudson L Vet Sci. 2017; 4(1).

PMID: 29056673 PMC: 5606611. DOI: 10.3390/vetsci4010014.


Novel GP64 envelope variants for improved delivery to human airway epithelial cells.

Sinn P, Hwang B, Li N, Ortiz J, Shirazi E, Parekh K Gene Ther. 2017; 24(10):674-679.

PMID: 28880020 PMC: 5759328. DOI: 10.1038/gt.2017.78.


Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.

Mamik M, Asahchop E, Chan W, Zhu Y, Branton W, McKenzie B J Neurosci. 2016; 36(41):10683-10695.

PMID: 27733618 PMC: 6601935. DOI: 10.1523/JNEUROSCI.1287-16.2016.


Human, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors.

Hornick A, Li N, Oakland M, McCray Jr P, Sinn P Hum Gene Ther. 2016; 27(5):354-62.

PMID: 27004832 PMC: 4840922. DOI: 10.1089/hum.2015.156.


References
1.
Sparger E, Shacklett B, Barry P, Pedersen N, Elder J, Luciw P . Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology. 1992; 187(1):165-77. DOI: 10.1016/0042-6822(92)90305-9. View

2.
Maki N, Miyazawa T, Fukasawa M, Hasegawa A, Hayami M, Miki K . Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch Virol. 1992; 123(1-2):29-45. DOI: 10.1007/BF01317136. View

3.
Poss M, Dow S, Hoover E . Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells. Virology. 1992; 188(1):25-32. DOI: 10.1016/0042-6822(92)90731-4. View

4.
Miyazawa T, Kawaguchi Y, Kohmoto M, Sakuragi J, Adachi A, Fukasawa M . Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone. J Gen Virol. 1992; 73 ( Pt 6):1543-6. DOI: 10.1099/0022-1317-73-6-1543. View

5.
Dow S, Dreitz M, Hoover E . Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol. 1992; 35(1-2):23-35. DOI: 10.1016/0165-2427(92)90118-a. View